Published in Diabetes Obes Metab on July 21, 2007
The metabolic syndrome. Endocr Rev (2008) 5.33
Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther (2008) 1.81
Insulin-like growth factor-1 deficiency and metabolic syndrome. J Transl Med (2016) 0.90
Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention. Drugs (2015) 0.86
P-selectin Plasma Levels and Genetic Variant Associated With Diabetic Retinopathy in African Americans. Am J Ophthalmol (2015) 0.83
Impaired glucose tolerance, but not impaired fasting glucose, is associated with retinopathy in Japanese population: the Funagata study. Diabetes Obes Metab (2008) 0.81
High Prevalence of Diabetic Retinopathy in Diabetic Patients Concomitant with Metabolic Syndrome. PLoS One (2016) 0.75
Determinants of developing diabetes mellitus and vascular complications in patients with impaired fasting glucose. Indian J Endocrinol Metab (2013) 0.75
FGF1 - a new weapon to control type 2 diabetes mellitus. Nat Rev Endocrinol (2017) 0.75
Variation in antibiotic use in the European Union. Lancet (2001) 6.02
[Increased risk of cancer with calcium antagonists?]. Lakartidningen (1996) 2.76
Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study. BMJ (1998) 2.56
Influence of food on the bioavailability of drugs. Clin Pharmacokinet (1978) 2.52
Enhancement of the bioavailability of propranolol and metoprolol by food. Clin Pharmacol Ther (1977) 2.23
What is the benefit of increasing the sulfonylurea dose? Ann Intern Med (1993) 2.16
Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials. BMJ (2000) 2.08
Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation. Diabetes (1980) 1.79
Evaluation and comparison of guidelines for the management of people with type 2 diabetes from eight European countries. Diabetes Res Clin Pract (2009) 1.79
Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study. Diabetes Care (1994) 1.79
Incidence of myocardial infarction in elderly men being treated with antihypertensive drugs: population based cohort study. BMJ (1996) 1.60
Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers. Eur J Epidemiol (2000) 1.59
Diastolic blood pressure and area of residence: multilevel versus ecological analysis of social inequity. J Epidemiol Community Health (2001) 1.52
Efficacy of dietary regulation in primary health care patients with hyperglycaemia detected by screening. Diabet Med (1988) 1.40
Polymorphism in the beta(1)-adrenergic receptor gene and hypertension. Circulation (2001) 1.35
Prescriptions with potential drug interactions dispensed at Swedish pharmacies in January 1999: cross sectional study. BMJ (2001) 1.33
Gender differences in knowledge, attitude, behavior and perceived oral health among adolescents. Acta Odontol Scand (1999) 1.33
Influence of food intake on presystemic clearance of drugs. Clin Pharmacokinet (1983) 1.32
Clinical pharmacology and primary health care in Europe--a gap to bridge. The WHO Working Group on Clinical Pharmacology in Europe. Eur J Clin Pharmacol (1990) 1.30
Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of pharmacokinetics and pharmacodynamics. Br J Clin Pharmacol (1997) 1.30
Comparison of excess costs of care and production losses because of morbidity in diabetic patients. Diabetes Care (1994) 1.22
Comparison of dose standard units for drug utilisation studies. Eur J Clin Pharmacol (1996) 1.21
Transplacental passage of atenolol in man. Eur J Clin Pharmacol (1978) 1.21
Is the blood chlorpropamide concentration critical in chlorpropamide alcohol flush? Lancet (1981) 1.18
A placebo-controlled dose-response study of felodipine extended release in hypertensive patients. J Cardiovasc Pharmacol (1989) 1.18
Acetylator phenotyping: a comparison of the isoniazid and dapsone tests. Eur J Clin Pharmacol (1981) 1.17
Accumulation of atenolol and metoprolol in human breast milk. Eur J Clin Pharmacol (1981) 1.16
Influence of cigarette smoking on goiter formation, thyroglobulin, and thyroid hormone levels in women. J Clin Endocrinol Metab (1984) 1.11
Factors influencing the detection rate of drug-related problems in community pharmacy. Pharm World Sci (1999) 1.10
Bioavailability of metronidazole in fasting and non-fasting healthy subjects and in patients with Crohn's disease. Eur J Clin Pharmacol (1977) 1.10
Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community. Diabetes Obes Metab (2004) 1.10
High-pressure liquid chromatographic determination of acetylsalicylic acid, salicylic acid, diflunisal, indomethacin, indoprofen and indobufen. Eur J Clin Pharmacol (1981) 1.10
High-performance liquid chromatographic determination of glipizide and some other sulfonylurea drugs in serum. J Chromatogr (1979) 1.09
Hypertension prevalence in obstructive sleep apnoea and sex: a population-based case-control study. Eur Respir J (2006) 1.08
Nephropathy, but not retinopathy, is associated with the development of heart disease in Type 1 diabetes: a 12-year observation study of 462 patients. Diabet Med (2005) 1.07
Evaluation of spiramycin as a therapeutic agent for elimination of nasopharyngeal pathogens. Possible use of spiramycin for middle ear infections and for gonococcal and meningococcal nasopharyngeal carriage. Scand J Infect Dis (1978) 1.06
Increased risk of obesity associated with the variant allele of the PPARGC1A Gly482Ser polymorphism in physically inactive elderly men. Diabetologia (2006) 1.04
Glucose tolerance and mortality, including a substudy of tolbutamide treatment. Diabetologia (1997) 1.03
Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension (2001) 1.03
Antihyperglycaemic efficacy, response prediction and dose-response relations of treatment with metformin and sulphonylurea, alone and in primary combination. Diabet Med (1994) 1.03
Increased mortality in Type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational study. Diabetologia (2000) 1.02
Improved effect of glibenclamide on administration before breakfast. Eur J Clin Pharmacol (1982) 1.01
Postural and symptomatic improvement after physiotherapy in patients with dizziness of suspected cervical origin. Arch Phys Med Rehabil (1996) 1.01
Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study. Diabet Med (2012) 1.00
Associations between smoking and beta-cell function in a non-hypertensive and non-diabetic population. Skaraborg Hypertension and Diabetes Project. Diabet Med (2000) 1.00
Body mass index and disability pension in middle-aged men--non-linear relations. Int J Epidemiol (1996) 1.00
Risk factor clustering in patients with hypertension and non-insulin-dependent diabetes mellitus. The Skaraborg Hypertension Project. J Intern Med (1998) 0.99
Higher education and more physical activity limit the development of obesity in a Swedish rural population. The Skaraborg Project. Int J Obes (Lond) (2008) 0.97
Effects of total energy withdrawal (fasting) on thelevels of growth hormone, thyrotropin, cortisol, adrenaline, noradrenaline, T4, T3, and rT3 in healthy males. Acta Med Scand (1977) 0.97
Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans. Diabetes Care (1994) 0.96
Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans. Diabetes Care (1991) 0.96
Worse glycaemic control in LADA patients than in those with type 2 diabetes, despite a longer time on insulin therapy. Diabetologia (2012) 0.95
A gender perspective of self-perceived oral health in adolescents: associations with attitudes and behaviours. Community Dent Health (2001) 0.95
Hyperglycaemia and absorption of sulphonylurea drugs. Lancet (1989) 0.95
Genetic variants of thiazide-sensitive NaCl-cotransporter in Gitelman's syndrome and primary hypertension. Hypertension (2000) 0.95
Pharmacokinetics of glibenclamide and its metabolites in diabetic patients with impaired renal function. Eur J Clin Pharmacol (1998) 0.94
Associations between body height, body composition and cholesterol levels in middle-aged men. the coronary risk factor study in southern Sweden (CRISS). Eur J Epidemiol (2001) 0.94
Effects of antithyroid drugs on lymphocyte function in vitro. J Clin Endocrinol Metab (1980) 0.93
Increased risk of ischaemic heart disease mortality in elderly men using anxiolytics-hypnotics and analgesics. Results of the 10-year follow-up of the prospective population study "Men born in 1914", Malmo, Sweden. Eur J Clin Pharmacol (1996) 0.92
Drug prescription attitudes and behaviour of general practitioners. Effects of a problem-oriented educational programme. Eur J Clin Pharmacol (1995) 0.92
Association testing of common variants in the insulin receptor substrate-1 gene (IRS1) with type 2 diabetes. Diabetologia (2007) 0.92
Understanding adherence to official guidelines on statin prescribing in primary health care--a multi-level methodological approach. Eur J Clin Pharmacol (2005) 0.92
Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period. J Clin Endocrinol Metab (1994) 0.91
Bioavailability of acetylsalicylic acid and salicylic acid from rapid-and slow-release formulations, and in combination with dipyridamol. Eur J Clin Pharmacol (1982) 0.91
Electrophysiological studies in newly onset type 2 diabetes without visible vascular retinopathy. Doc Ophthalmol (2011) 0.90
Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects. Eur J Clin Pharmacol (1980) 0.90
Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM. Diabetes (1993) 0.90
Excretion of paracetamol in human breast milk. Eur J Clin Pharmacol (1981) 0.90
Influence of food and age on the single-dose kinetics and effects of tolbutamide and chlorpropamide. Eur J Clin Pharmacol (1980) 0.89
Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment. Diabetes Care (1988) 0.89
Appearance of amine-containing mast cells in the mouse thyroid induced by the human long-acting thyroid stimulator (LATS). Endocrinology (1973) 0.89
Beta2-adrenergic stimulation of thyroid hormone secretion. Endocrinology (1975) 0.89
Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide. Diabetologia (1980) 0.89
Effects and serum levels of glibenclamide and its active metabolites in patients with type 2 diabetes. Diabetes Obes Metab (2001) 0.89
Exocytosis of protein into the thyroid follicle lumen: an early effect of TSH. Endocrinology (1975) 0.89
Sulphonylureas in the treatment of non-insulin-dependent diabetes. Baillieres Clin Endocrinol Metab (1988) 0.88
Enhancement of hydralazine bioavailability by food. Clin Pharmacol Ther (1977) 0.88
Poor metabolic control, early age at onset, and marginal folate deficiency are associated with increasing levels of plasma homocysteine in insulin-dependent diabetes mellitus. A five-year follow-up study. Scand J Clin Lab Invest (1997) 0.88
Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus. Br Med J (1978) 0.88
Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels. Diabetologia (2006) 0.88
Significance of thyroid mast cells in thyroid hormone secretion. Endocrinology (1972) 0.87
Effects and plasma levels of propranolol and metoprolol in hyperthyroid patients. Eur J Clin Pharmacol (1980) 0.87
In vivo action of vinblastine on thyroid ultrastructure and hormone secretion. Endocrinology (1974) 0.87
Blood levels of 3,5,3'-triiodothyronine and thyroxine: differences between children, adults, and elderly subjects. Acta Med Scand (1976) 0.87
Glycaemic control, disease duration and beta-cell function in patients with Type 2 diabetes in a Swedish community. Skaraborg Hypertension and Diabetes Project. Diabet Med (2002) 0.87
Intra-urban variation of antibiotic utilization in children: influence of socio-economic factors. Eur J Clin Pharmacol (1998) 0.87
Core Standards of the EUBIROD Project. Defining a European Diabetes Data Dictionary for Clinical Audit and Healthcare Delivery. Methods Inf Med (2015) 0.87
Transplacental passage and breast milk concentrations of hydralazine. Eur J Clin Pharmacol (1982) 0.86
Prescribing, prescription costs and adherence to formulary committee recommendations: long-term differences between physicians in public and private care. Eur J Clin Pharmacol (2001) 0.86
Polymorphism in the angiotensin converting enzyme but not in the angiotensinogen gene is associated with hypertension and type 2 diabetes: the Skaraborg Hypertension and diabetes project. J Hypertens (1999) 0.86
Influence of food on the absorption of phenytoin in man. Eur J Clin Pharmacol (1979) 0.86
Socioeconomic factors, morbidity and drug utilization--an ecological study. Pharmacoepidemiol Drug Saf (1998) 0.86